BUZZ-Aptose Biosciences Inc: FDA puts cancer drug trial on hold

Fri Nov 20, 2015 9:40am EST
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Drug developer's U.S listed shares slump as much as 36 pct to a 2-year low of $3.41

** Stock, down 32 pct, was on track for its worst day in three years

** Aptose says FDA put its early-stage trial on a cancer drug on hold after a review found a malfunctioning infusion pump at a clinical site where the tests were being held

** Company expects delays in the trial but says review finding does not undermine the positive safety profile of the drug

** Up to Thursday's close, the U.S.-listed stock had fallen 10 pct this year